About

Winnie has extensive experience launching and building life science companies and has successfully commercialized disruptive technologies that resulted in successful exits. These technologies include the analytical systems for drug development at ForteBio, Inc. (acquired by Pall Corp.); the anatomical pathology systems for cancer diagnosis at Becton Dickinson, the cell analysis systems at Guava Technologies, Inc. (acquired by Millipore); and the HIV drug testing model at SyStemix, Inc. (acquired by Novartis).